1. Home
  2. CVM vs MSAI Comparison

CVM vs MSAI Comparison

Compare CVM & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • MSAI
  • Stock Information
  • Founded
  • CVM 1983
  • MSAI 1995
  • Country
  • CVM United States
  • MSAI United States
  • Employees
  • CVM N/A
  • MSAI N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • MSAI
  • Sector
  • CVM Health Care
  • MSAI
  • Exchange
  • CVM Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • CVM 35.7M
  • MSAI 29.7M
  • IPO Year
  • CVM 1987
  • MSAI N/A
  • Fundamental
  • Price
  • CVM $0.56
  • MSAI $1.64
  • Analyst Decision
  • CVM
  • MSAI Strong Buy
  • Analyst Count
  • CVM 0
  • MSAI 1
  • Target Price
  • CVM N/A
  • MSAI $8.00
  • AVG Volume (30 Days)
  • CVM 459.4K
  • MSAI 11.9K
  • Earning Date
  • CVM 12-19-2024
  • MSAI 11-12-2024
  • Dividend Yield
  • CVM N/A
  • MSAI N/A
  • EPS Growth
  • CVM N/A
  • MSAI N/A
  • EPS
  • CVM N/A
  • MSAI N/A
  • Revenue
  • CVM N/A
  • MSAI $7,616,000.00
  • Revenue This Year
  • CVM N/A
  • MSAI $208.07
  • Revenue Next Year
  • CVM $3,412.81
  • MSAI $143.29
  • P/E Ratio
  • CVM N/A
  • MSAI N/A
  • Revenue Growth
  • CVM N/A
  • MSAI 30.50
  • 52 Week Low
  • CVM $0.54
  • MSAI $1.51
  • 52 Week High
  • CVM $3.23
  • MSAI $14.00
  • Technical
  • Relative Strength Index (RSI)
  • CVM 14.93
  • MSAI 31.20
  • Support Level
  • CVM $0.54
  • MSAI $1.89
  • Resistance Level
  • CVM $0.92
  • MSAI $2.01
  • Average True Range (ATR)
  • CVM 0.06
  • MSAI 0.12
  • MACD
  • CVM -0.02
  • MSAI -0.03
  • Stochastic Oscillator
  • CVM 5.18
  • MSAI 2.38

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc develops and sells a full-stack, AI-driven predictive maintenance solution. MultiSensor AI's SmartIR and associated software platforms, powered by AWS, leverage MSAI-built thermal imaging, visible imaging, acoustic imaging, vibration, and laser sensing devices for condition-based monitoring of critical mechanical and electrical assets and manufactured outputs. Its solutions are deployed by organizations to protect critical assets across a wide range of industries including distribution & logistics, manufacturing, utilities, and oil & gas. MSAI designs and manufactures digital thermal sensing solution platforms with edge and cloud-based software. The company generates the majority of its revenue from product sales.

Share on Social Networks: